Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05299944 · ClinicalTrials.gov registry record · Phase 2

Reducing Pain and Opioid Use With CBD

A Phase 2 study of Opioid Use Disorder, sponsored by University of Colorado, Denver.

Completed
Registry status
Phase 2
Development phase
126
Enrollment target
2
Study locations

NCT05299944 is a Phase 2 study of Opioid Use Disorder that has completed, run by University of Colorado, Denver. The registered enrollment target is 126 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05299944, a Phase 2 study of Opioid Use Disorder, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
Phase 2
Development phase
126 participants
Enrollment target
2
Study locations

Study Summary

This is a double-blind, placebo-controlled, parallel group study designed to assess the tolerability and efficacy of fsCBD and bsCBD, compared to a placebo control, to reduce opioid use, anxiety, and pain and improve sleep and cognitive function. If eligible for the study, subjects will be randomized to receive one of the conditions for 12 weeks.

Conditions Studied

Opioid Use Disorder

Interventions

  • DRUG Placebo
  • DRUG Cannabidiol

Study Locations (2)

Colorado

  • University of Colorado - Anschutz Medical Campus - Aurora
  • University of Colorado Denver - Aurora

Trial Details

FieldValue
Enrollment Target 126 participants
Start Date 2022-03-08
Est. Completion 2025-08-19
Phase Phase 2

Sponsor

University of Colorado, Denver

1,283 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05299944

The ClinicalTrials.gov registry entry for NCT05299944 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (97% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05299944 reports 2 study locations spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT05299944 about?

NCT05299944 is a clinical study titled "Reducing Pain and Opioid Use With CBD". This is a double-blind, placebo-controlled, parallel group study designed to assess the tolerability and efficacy of fsCBD and bsCBD, compared to a placebo control, to reduce opioid use, anxiety, and pain and improve sleep and cognitive function. If eligible for the study, subjects will be randomize...

What is the current status of trial NCT05299944?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 126 participants. The study started on 2022-03-08. Estimated completion is 2025-08-19.

What conditions does trial NCT05299944 study?

This clinical trial studies the following conditions: Opioid Use Disorder.

What interventions are being tested in trial NCT05299944?

The interventions under investigation include: Placebo (DRUG), Cannabidiol (DRUG).

Who is sponsoring clinical trial NCT05299944?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05299944 being conducted?

This trial has 2 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Opioid Use Disorder

All registered trials for this condition

Colorado

All trials with a study site in Colorado

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.